The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of topotecan, vinorelbine, thiotepa, and gemcitabine (TVTG) chemotheapy in relapsed/refractory adult acute leukemia: A single-institution retrospective analysis.
S. A. Srour
No relevant relationships to disclose
M. A. Cherry
No relevant relationships to disclose
E. Borders
No relevant relationships to disclose
H. Parekh
No relevant relationships to disclose
J. L. Holter
No relevant relationships to disclose
T. S. Herman
No relevant relationships to disclose
G. B. Selby
No relevant relationships to disclose